Syncom Formulations (India) Limited - Company Profile

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 1988.

1988 Mumbai, Maharashtra, India Active

Last Updated: December 18, 2025

About Syncom Formulations (India) Limited

Syncom Formulations (India) Limited, a active public limited company, was established on 21 June 1988 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24239MH1988PLC047759. Registered under ROC Roc Mumbai. it is listed on BSE: 524470. It has an authorized capital of ₹95.00 Cr and a paid-up capital of ₹94.00 Cr.

Formerly known as Syncom Formulations (India) Pvt Limited. It upholds a compliant status. Employing 681 professional, Its leadership includes Ritesh Kumar Lunkad (Director), Ankit Jain (Director), Kedarmal Shankarlal Bankda (Whole-Time Director). Past directors included Praveen Jindal, Arpit Gupta, Ramesh Mishra. It holds ₹9.50 Cr open charges and ₹156.68 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2025. It is based at 7, Niraj Industrial Estate, Off Mahakali Caves Road Andheri (East), Mumbai, Maharashtra, 400093.

Company Details

CIN/LLPIN
L24239MH1988PLC047759
Registration Number
047759
Incorporation Date
21 June 1988
Authorized Capital
₹95.00 Cr
Paid-Up Capital
₹94.00 Cr
ROC Code
Roc Mumbai
Listing Status
Listed (BSE: 524470)
Company Status
Active

Key Metrics

Authorised Capital ₹ 95.00 Cr as on 18-12-2025
Paid Up Capital ₹ 94.00 Cr as on 18-12-2025
Company Age 37 Year, 11 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 9.50 Cr as on 18-12-2025
Satisfied Charges ₹ 156.68 Cr as on 18-12-2025
Revenue Growth **** -97.83% (FY 2025)
Profit Growth **** -105.24% (FY 2025)
Ebitda **** -100.83% (FY 2025)
Net Worth -105.19% (FY 2025)
Total Assets -96.47% (FY 2025)

Comprehensive Company Insights

Explore comprehensive insights into Syncom Formulations (India) Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Syncom Formulations (India) Limited?

Current Directors

Name	Designation	Appointment Date	Status
Ritesh Kumar Lunkad	Director	14 Aug 2023	Current
Ankit Jain	Director	14 Aug 2023	Current
Kedarmal Shankarlal Bankda	Whole-Time Director	13 Apr 1992	Current
Vijay Shankarlal Bankda	Officer In Default	08 Aug 2025	Current
Rahul Vijay Bankda	Cfo	09 Aug 2025	Current
Ruchi Jindal	Director	28 Jun 2022	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	28 Sep 2012	Past
Pramod Abcsdd	Director	01 Oct 2008	Past
Pramod Abcsdd	Director	30 Apr 2007	Past
Pramod Abcsdd	Director	31 Mar 2024	Past
Pramod Abcsdd	Additional Director	25 Sep 2023	Past
Pramod Abcsdd	Director	12 Jul 2012	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Syncom Formulations (India).

Syncom Formulations (India) Limited, for the financial year ended 2025, experienced significant reduction in revenue, with a 97.83% decrease. The company also saw a substantial fall in profitability, with a 105.24% decrease in profit. The company's net worth observed a substantial decline by a decrease of 105.19%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-97.83%

*******

Revenue from Operations

*******

-97.72%

*******

Total Assets

*******

-96.47%

*******

Profit or Loss

*******

-105.24%

*******

Net Worth

*******

-105.19%

*******

EBITDA

*******

-100.83%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Syncom Formulations (India)?

In 2024, Syncom Formulations (India) had a promoter holding of 50.57% and a public holding of 49.43%. The company had 3 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹95,000,000.00

Satisfied Charges

₹1,566,792,000.00

Charges Breakdown by Lending Institutions

Hdfc Bank Limited : 9.50 Cr

Latest Charge Details

Date	Lender	Amount	Status
01 Oct 2025	Hdfc Bank Limited	₹9.50 Cr	Open
28 Dec 2020	Hdfc Bank Limited	₹100.00 Cr	Satisfied
23 May 2002	Dena Bank	₹12.77 Cr	Satisfied
23 May 2002	Dena Bank	₹12.77 Cr	Satisfied
27 Mar 2000	Dena Bank	₹4.00 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Syncom Formulations (India)?

Syncom Formulations (India) has a workforce of 681 employees as of Mar 27, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Syncom Formulations (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Syncom Formulations (India)'s trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Syncom Formulations (India)

Recent Activity within the Organization

Charges

The activity A charge with Hdfc Bank Limited amounted to Rs. 9.50 Cr with Charge ID 101172185 was registered on 01 Oct 2025. was completed.
01 Oct 2025
Director Appointment

Progress on Rahul Vijay Bankda was appointed as a Cfo was appointed as a Cfo on 08 Sep 2025 & has been associated with this company since 8 months 16 days . was documented.
08 Sep 2025
Director Appointment

Rahul Vijay Bankda was appointed as a CFO was appointed as a CFO on 09 Aug 2025 & has been associated with this company since 9 months 16 days . was recorded as a recent event.
09 Aug 2025
Director Appointment

The activity Ankit Kedarmal Bankda was appointed as a Whole-time director was appointed as a Whole-time director on 09 Aug 2025 & has been associated with this company since 9 months 16 days . was completed.
09 Aug 2025
Director Appointment

Progress on Vijay Shankarlal Bankda was appointed as a Officer in default was appointed as a Officer in default on 08 Aug 2025 & has been associated with this company since 9 months 17 days . was documented.
08 Aug 2025
Balance Sheet

The activity Syncom Formulations (India) Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.
31 Mar 2025

Explore recent activity and updates - View Recent Activity